This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Current level of evidence on causal association between Hepatitis C virus and type 2 diabetes: A review
Publication date: Available online 2 December 2016 Source:Journal of Advanced Research Author(s): Giacomo Gastaldi, Nicolas Goossens, Sophie Clément, Francesco Negro The association between hepatitis C virus (HCV) infection and type 2 diabetes (T2D) has been known for over 20 years. Cross-sectional and longitudinal studies have shown a higher prevalence and incidence, respectively, of T2D in patients with chronic HCV infection. HCV induces glucose metabolism alterations mostly interfering with the insulin signalling chain in hepatocytes, although extrahepatic mechanisms seem to contribute. Both IR and T2D accelerate the ...
Source: Journal of Advanced Research - December 2, 2016 Category: Research Source Type: research
Reversing the effects of the new anti-clotting drugs
The oral anticoagulant warfarin (Coumadin) became available for prescription in 1954. This anti-clotting drug commanded national attention when President Dwight Eisenhower received the drug as part of his treatment following a heart attack. No other oral anticoagulant was successfully developed and marketed in the United States until 2010. Warfarin is a dangerous drug. Along with insulin, it is responsible for the most emergency hospitalizations due to adverse drug reactions. Whereas insulin causes low blood sugar, warfarin is notorious for the complication of major bleeding. Warfarin is plagued by hundreds of drug-drug an...
Source: New Harvard Health Information - December 9, 2015 Category: Consumer Health News Authors: Samuel Z. Goldhaber, MD Tags: Drugs and Supplements Health Heart Health Hypertension and Stroke anti-clotting coumadin deep-vein-thrombosis DVT Source Type: news